Ranking Vaccines: A Prioritization Software Tool: Phase II: Prototype of a Decision-Support System (2013)
Chapter: Appendix E: Stakeholder Speakers
BRUCE GELLIN (Sponsor), Deputy Assistant Secretary of Health; Director, National Vaccine Program Office, Department of Health and Human Services
PHYLLIS ARTHUR, Senior Director, Vaccines, Immunotherapeutics and Diagnostics Policy, Biotechnology Industry Organization
JOHN BOSLEGO, Director, Vaccine Development Program, PATH
CARTER DIGGS, Senior Technical Advisor, Malaria Vaccine Development Program, U.S. Agency for International Development
PHILIP ECKHOFF, Research Scientist and Principal Investigator, Disease Modeling Team, Intellectual Ventures
IRENE ECKSTRAND, Scientific Officer, Models of Infectious Disease Agent Study, National Institute of General Medical Sciences, National Institutes of Health
RAINER ENGELHARDT, Assistant Deputy Minister, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada
ALEXANDER GARZA, Assistant Secretary for Health Affairs and Chief Medical Officer, Department of Homeland Security
ANN GINSBERG, Vice President, Scientific Affairs, Aeras
MARION GRUBER, Director, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration
DAVID HAMMER, Product Manager, Joint Vaccine Acquisition Program, Chemical Biological Medical Systems, Department of Defense
CAROLE HEILMAN, Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health
SETH HETHERINGTON, Chief Medical Officer, Genocea Biosciences; Member, National Vaccine Advisory Committee
JOACHIM HOMBACH, Senior Adviser, Department of Immunisation, Vaccines and Biologicals, World Health Organization
PETER HOTEZ, President, Albert Sabin Vaccine Institute, and Dean, National School of Tropical Medicine, Baylor College of Medicine
ROBERT KOLODNER, Chief Health Informatics Officer and Acting Executive Officer, Open Health Tools
PRASAD KULKARNI, Medical Director, The Serum Institute of India Limited
DIANA LANCHONEY, Executive Director, Vaccine Ventures and New Products, Merck & Company
TIMOTHY LANT, Director, Analytic Decision Support, Biomedical Advanced Research and Development Authority, Department of Health and Human Services
OSMAN MANSOOR, Senior Health Advisor, New Vaccines, United Nations Children’s Fund
RICHARD MARTINELLO, Chief Consultant, Clinical Public Health, Department of Veterans Affairs
GENEVIEVE MEIER, Health Economics Manager, North America Vaccines Division, GlaxoSmithKline Vaccines
CHRISTOPHER MURRAY, Director, Institute for Health Metrics and Evaluation, University of Washington School of Medicine
ALEX PALACIOS, Special Representative, GAVI Alliance
PATRICIA QUINLISK, Medical Director, Iowa Department of Health
ROBIN ROBINSON, Director, Biomedical Advanced Research and Development Authority, Department of Health and Human Services
JEFFREY STURCHIO, Senior Partner, Rabin Martin
MELINDA WHARTON, Deputy Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
